MonoSol Rx Appoints
MonoSol Rx Appoints James S. Scibetta to Board of Directors
April 11, 2017 08:30 ET | MonoSol Rx
WARREN, N.J., April 11, 2017 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® technology to develop and bring to market products that improve patient...
MonoSol Rx Receives
MonoSol Rx Receives FDA Acceptance of New Drug Application for Tadalafil PharmFilm®
February 07, 2017 08:30 ET | MonoSol Rx
WARREN, N.J., Feb. 07, 2017 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet...
MonoSol Rx Appoints
MonoSol Rx Appoints John T. Maxwell as Chief Financial Officer
January 24, 2017 08:30 ET | MonoSol Rx
WARREN, N.J., Jan. 24, 2017 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet...
MonoSol Rx Files Pat
MonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences International (BDSI)
January 13, 2017 15:39 ET | MonoSol Rx
WARREN, N.J., Jan. 13, 2017 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company utilizing its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet...
MonoSol Rx to Initia
MonoSol Rx to Initiate Human Proof-of-Concept Study of Epinephrine Sublingual Soluble Film
January 10, 2017 08:30 ET | MonoSol Rx
WARREN, N.J., Jan. 10, 2017 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet...
MonoSol Rx Successfu
MonoSol Rx Successfully Completes Dose Proportionality Study of Diazepam Buccal Soluble Film to Treat Acute Repetitive Seizures
January 06, 2017 08:30 ET | MonoSol Rx
WARREN N.J., Jan. 06, 2017 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet...
MonoSol Rx Receives
MonoSol Rx Receives FDA Acceptance of Investigational New Drug Application for Riluzole Oral Soluble Film to Treat Amyotrophic Lateral Sclerosis
January 05, 2017 08:30 ET | MonoSol Rx
WARREN, N.J., Jan. 05, 2017 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet...
MonoSol Rx Receives
MonoSol Rx Receives FDA Orphan Drug Designation for Diazepam Buccal Soluble Film to Treat Acute Repetitive Seizures
November 30, 2016 08:30 ET | MonoSol Rx
WARREN, N.J., Nov. 30, 2016 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet...
MonoSol Rx Submits N
MonoSol Rx Submits New Drug Application for Tadalafil PharmFilm®
November 28, 2016 08:30 ET | MonoSol Rx
Warren N.J., Nov. 28, 2016 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to improve patient outcomes and to address unmet...
UPDATE -- Lupin and
UPDATE -- Lupin and MonoSol Rx Announce Licensing Agreement for Multiple Pediatric-Focused Products
October 06, 2016 12:31 ET | MonoSol Rx
WARREN, N.J. and BALTIMORE and MUMBAI, India, Oct. 06, 2016 (GLOBE NEWSWIRE) -- Lupin Pharmaceutical Inc., the US subsidiary of pharma major Lupin Limited (collectively Lupin) and MonoSol Rx, a...